• 1
    Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, et. al. Prescription drug use in pregnancy. Am J Obstet Gynecol.2004; 191(2): 398407.
  • 2
    Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol.2008; 65(5): 653660.
  • 3
    Updated Interim Recommendations for Obstetric Health Care Providers Related to Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season. The Centers for Disease Control and Prevention. 2009 [cited 2009 September 24]; Available from:
  • 4
    United States General Accounting Office GAO/HRD-93-17. Women’s Health – FDA needs to ensure more study of gender differences in prescription drug testing. 1992.
  • 5
    Hebert MF, Carr DB, Anderson GD, Blough D, Green GE, Brateng DA, Kantor E, Benedetti TJ, Easterling TR. Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol.2005; 45(1): 2533.
  • 6
    Andrew MA, Easterling TR, Carr DB, Shen D, Buchanan ML, Rutherford T, Bennett P, Vicini P, Hebert MF. Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther.2007; 81(4): 547556.
  • 7
    Freeman MP, Nolan PE Jr, Davis MF, Anthony M, Fried K, Fankhauser M, Woolsey RL, Moreno F. Pharmacokinetics of sertraline across pregnancy and postpartum. J Clin Psychopharmacol.2008; 28(6): 646653.
  • 8
    Shields KE, Wiholm BE, Hostelley LS, Striano LF, Arena SR, Sharrar RG. Monitoring outcomes of pregnancy following drug exposure: a company-based pregnancy registry program. Drug Saf.2004; 27(6): 353367.
  • 9
    Guidance for Industry Establishing Pregnancy Exposure Registries. Rockville , MD : U. S. Food and Drug Administration; 2002.
  • 10
    Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, Mathews TJ. Births: final data for 2006. Natl Vital Stat Rep.2009; 57(7), 102 pp.
  • 11
    Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2008. Natl Vital Stat Rep.2010; 58(16): 117.
  • 12
    Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med.2009; 122(10): 890895.
  • 13
    Schatz M, Dombrowski MP. Clinical practice. Asthma in pregnancy. N Engl J Med.2009; 360(18): 18621869.
  • 14
    Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol.2009; 114(3): 703713.
  • 15
    BriggsGG, NageotteMP, editors. Diseases, Complications, and Drug Therapy in Obstetrics: A guide for clinicians. Bethesda , MD : American Society of Health-Systems Pharmacists; 2009.
  • 16
    Tan TC, Devendra K, Tan LK, Tan HK. Tocolytic treatment for the management of preterm labour: a systematic review. Singapore Med J.2006; 47(5): 361366.
  • 17
    Tsatsaris V, Cabrol D, Carbonne B. Pharmacokinetics of tocolytic agents. Clin Pharmacokinet.2004; 43(13): 833844.
  • 18
    Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med.1999; 341(19): 14471457.
  • 19
    Ferguson JE 2nd, Schutz T, Pershe R, Stevenson DK, Blaschke T. Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol.1989; 161(6 Pt 1): 14851490.
  • 20
    Madden C, Owen J, Hauth JC. Magnesium tocolysis: serum levels versus success. Am J Obstet Gynecol.1990; 162(5): 11771180.
  • 21
    Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med.2000; 343(16): 11341138.
  • 22
    Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med.2008; 358(19): 20032015.
  • 23
    Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, Caritis SN, Miodovnik M, Mattison DR, Unadkat JD, et. al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther2009; 85(6): 607614.
  • 24
    Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD, Clark SM, Risler L, Wang J, Kelly EJ, et. al. Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos.2010; 38(5): 833840.
  • 25
    Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet.2006; 368(9536): 704.
  • 26
    NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. 2001. Available at: Accessed October 14, 2008.
  • 27
    Haas DM, Wunder K, Wolf JG, Denne SC. Women’s health care providers’ attitudes toward research in pregnancy. J Reprod Med.2010; 55(3-4): 108114.
  • 28
    Mazzotta P, Stewart D, Atanackovic G, Koren G, Magee LA. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. J Psychosom Obstet Gynaecol.2000; 21(3): 129136.
  • 29
    Gill SK, Maltepe C, Koren G. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Can J Gastroenterol.2009; 23(4): 270272.
  • 30
    Magee LA, Elran E, Bull SB, Logan A, Koren G. Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol.2000; 88(1): 1526.
  • 31
    Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ.1990; 301(6752): 587589.